Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Girdin (GIV) Expression as a Prognostic Marker of Recurrence in Mismatch Repair-Proficient Stage II Colon Cancer.
Ghosh P, Tie J, Muranyi A, Singh S, Brunhoeber P, Leith K, Bowermaster R, Liao Z, Zhu Y, LaFleur B, Tran B, Desai J, Jones I, Croxford M, Jover R, Goel A, Waring P, Hu S, Teichgraber V, Rohr UP, Ridder R, Shanmugam K, Gibbs P. Ghosh P, et al. Among authors: jover r. Clin Cancer Res. 2016 Jul 15;22(14):3488-98. doi: 10.1158/1078-0432.CCR-15-2290. Epub 2016 Mar 30. Clin Cancer Res. 2016. PMID: 27029492 Free PMC article.
Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency.
Castells A, Payá A, Alenda C, Rodríguez-Moranta F, Agrelo R, Andreu M, Piñol V, Castellví-Bel S, Jover R, Llor X, Pons E, Elizalde JI, Bessa X, Alcedo J, Saló J, Medina E, Naranjo A, Esteller M, Piqué JM; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Castells A, et al. Among authors: jover r. Clin Cancer Res. 2006 Mar 15;12(6):1686-92. doi: 10.1158/1078-0432.CCR-05-1581. Clin Cancer Res. 2006. PMID: 16551850
Utility of p16 immunohistochemistry for the identification of Lynch syndrome.
Payá A, Alenda C, Pérez-Carbonell L, Rojas E, Soto JL, Guillén C, Castillejo A, Barberá VM, Carrato A, Castells A, Llor X, Andreu M, Koh J, Enders GH, Benlloch S, Jover R. Payá A, et al. Among authors: jover r. Clin Cancer Res. 2009 May 1;15(9):3156-62. doi: 10.1158/1078-0432.CCR-08-3116. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383812 Free PMC article.
Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency.
Goel A, Xicola RM, Nguyen TP, Doyle BJ, Sohn VR, Bandipalliam P, Rozek LS, Reyes J, Cordero C, Balaguer F, Castells A, Jover R, Andreu M, Syngal S, Boland CR, Llor X. Goel A, et al. Among authors: jover r. Gastroenterology. 2010 May;138(5):1854-62. doi: 10.1053/j.gastro.2010.01.035. Epub 2010 Jan 25. Gastroenterology. 2010. PMID: 20102720 Free PMC article.
Colorectal cancers with microsatellite instability display unique miRNA profiles.
Balaguer F, Moreira L, Lozano JJ, Link A, Ramirez G, Shen Y, Cuatrecasas M, Arnold M, Meltzer SJ, Syngal S, Stoffel E, Jover R, Llor X, Castells A, Boland CR, Gironella M, Goel A. Balaguer F, et al. Among authors: jover r. Clin Cancer Res. 2011 Oct 1;17(19):6239-49. doi: 10.1158/1078-0432.CCR-11-1424. Epub 2011 Aug 15. Clin Cancer Res. 2011. PMID: 21844009 Free PMC article.
IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer.
Perez-Carbonell L, Balaguer F, Toiyama Y, Egoavil C, Rojas E, Guarinos C, Andreu M, Llor X, Castells A, Jover R, Boland CR, Goel A. Perez-Carbonell L, et al. Among authors: jover r. PLoS One. 2014 Aug 15;9(8):e104285. doi: 10.1371/journal.pone.0104285. eCollection 2014. PLoS One. 2014. PMID: 25127039 Free PMC article.
TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer.
Murcia O, Jover R, Egoavil C, Perez-Carbonell L, Juárez M, Hernández-Illán E, Rojas E, Alenda C, Balaguer F, Andreu M, Llor X, Castells A, Boland CR, Goel A. Murcia O, et al. Among authors: jover r. Clin Cancer Res. 2018 Jun 15;24(12):2820-2827. doi: 10.1158/1078-0432.CCR-17-2940. Epub 2018 Mar 13. Clin Cancer Res. 2018. PMID: 29535127 Free PMC article.
Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway.
Llor X, Pons E, Xicola RM, Castells A, Alenda C, Piñol V, Andreu M, Castellví-Bel S, Payá A, Jover R, Bessa X, Girós A, Roca A, Gassull MA; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Llor X, et al. Among authors: jover r. Clin Cancer Res. 2005 Oct 15;11(20):7304-10. doi: 10.1158/1078-0432.CCR-05-0965. Clin Cancer Res. 2005. PMID: 16243801
341 results